Clinical Features Associated with Glutamic Acid Decarboxylase Autoantibodies (GADA) in Adults with Type 2 Diabetes

被引：0
|
作者：
Pilla, Scott J.
Knowler, William C.
Balasubramanyam, Ashok
Hampe, Christiane S.
Pietropaolo, Susan
Anderson, Andrea M.
Li, Mo
Zhao, Ni
Zeger, Scott L.
Ramelius, Anita
Bennet, Rasmus
Lernmark, Ake
Mathioudakis, Nestoras N.
Clark, Jeanne
Maruthur, Nisa M.
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-1388-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1388-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical features associated with glutamic acid decarboxylase autoantibodies (GADA) in adults with type 2 diabetes
    Maruthur, N. M.
    Knowler, W. C.
    Balasubramanyam, A.
    Hampe, C. S.
    Pietropaolo, S.
    Anderson, A.
    Li, M.
    Zhao, N.
    Zeger, S. L.
    Ramelius, A.
    Bennet, R.
    Lernmark, A.
    Mathioudakis, N. N.
    Clark, J. M.
    Pilla, S. J.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S227 - S227
  • [2] Glutamic Acid Decarboxylase Autoantibodies (GADA) in Type 2 Diabetes Do Not Predict Long-Term Diabetes Complications
    Pilla, Scott J.
    Knowler, William C.
    Balasubramanyam, Ashok
    Hampe, Christiane S.
    Pietropaolo, Susan
    Anderson, Andrea M.
    Li, Mo
    Zhao, Ni
    Zeger, Scott L.
    Ramelius, Anita
    Bennet, Rasmus
    Lernmark, Ake
    Mathioudakis, Nestoras N.
    Clark, Jeanne
    Maruthur, Nisa M.
    [J]. DIABETES, 2023, 72
  • [3] Glutamic Acid Decarboxylase Autoantibodies (GADA) in Type 2 Diabetes Predict Glycemic Control over 16 Years
    Pilla, Scott J.
    Knowler, William C.
    Balasubramanyam, Ashok
    Hampe, Christiane S.
    Pietropaolo, Susan
    Anderson, Andrea M.
    Li, Mo
    Zhao, Ni
    Zeger, Scott L.
    Ramelius, Anita
    Bennet, Rasmus
    Lernmark, Ake
    Mathioudakis, Nestoras N.
    Clark, Jeanne
    Maruthur, Nisa M.
    [J]. DIABETES, 2023, 72
  • [4] Glutamic acid decarboxylase autoantibodies (GADA) in type 2 diabetes predict long-term glycaemic control but not complications
    Pilla, S. J.
    Knowler, W. C.
    Balasubramanyam, A.
    Hampe, C. S.
    Pietropaolo, S.
    Anderson, A.
    Li, M.
    Zhao, N.
    Zeger, S. L.
    Ramelius, A.
    Bennet, R.
    Lernmark, A.
    Mathioudakis, N. N.
    Clark, J. M.
    Maruthur, N. M.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S227 - S228
  • [5] Associated autoimmunity in Type 1 Diabetes and latent autoimmune diabetes of adults: The role of glutamic-acid decarboxylase autoantibodies
    Gougourelas, Dimitrios
    Tsentidis, Charalampos
    Koufadaki, Athina Maria
    Koutsovasilis, Anastasios
    Gougourela, Eupraxia
    Karanasios, Spyridon
    Sotiropoulos, Alexios
    Bousboulas, Stavros
    Karavanaki, Kyriaki Athina
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 175
  • [6] Epilepsy associated with glutamic acid decarboxylase antibody (GADA)
    Liimatainen, S.
    Peltola, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (06) : 799 - 799
  • [7] Autoantibodies to glutamic acid decarboxylase and type 2 diabetes in a mediterranean community:: prevalence and clinical phenotype.
    Fernández-Fernández, F
    Vidal, J
    Rodríguez-Villar, C
    Conget, I
    Casamitjana, R
    Gomis, R
    [J]. DIABETOLOGIA, 1998, 41 : A92 - A92
  • [8] Glutamic acid decarboxylase autoantibodies in saliva of children with type 1 diabetes
    Markopoulos, AK
    Belazi, MA
    Drakoulakos, D
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1997, 38 (03) : 169 - 172
  • [9] Pathogenetic and clinical significance of autoantibodies to glutamic acid decarboxylase in diabetes development
    Piven, N.
    Orlova, E.
    Lukhverchyk, L.
    [J]. ALLERGY, 2010, 65 : 463 - 464
  • [10] Encephalitis associated with glutamic acid decarboxylase autoantibodies
    Marchiori, GC
    Vaglia, A
    Vianello, M
    Bardin, PG
    Giometto, B
    [J]. NEUROLOGY, 2001, 56 (06) : 814 - 814
12345